Katherine N Keenan

Title: Katherine N Keenan: Innovator in Protein Kinase C Modulators

Introduction

Katherine N Keenan is a prominent inventor based in Stanford, California. She has made significant contributions to the field of pharmacology, particularly in the development of prodrug derivatives of protein kinase C modulators. Her innovative work focuses on creating compounds that exhibit efficacy while minimizing toxicity and enhancing stability.

Latest Patents

Keenan holds a patent for "Prodrug derivatives of protein kinase C modulators." This patent describes embodiments of prodrugs that are useful in academic research, preclinical studies, and as therapeutic agents. The design strategy utilizes a pharmacophore-based approach, allowing access to prodrugs of various scaffolds, including tigliane diterpenes, ingenane diterpenes, daphnane diterpene orthoesters, diacylglycerols, and bryostatins. Notably, her work includes ingenane esters with specific substitutions at C20, highlighting their potential as therapeutic agents.

Career Highlights

Katherine N Keenan is affiliated with Leland Stanford Junior University, where she continues her research and development in pharmacology. Her work has garnered attention for its innovative approach to drug design and its implications for therapeutic applications.

Collaborations

Keenan has collaborated with notable colleagues, including Paul A Wender and Nancy Lynn Benner. These partnerships have contributed to her research and the advancement of her patented technologies.

Conclusion

Katherine N Keenan's contributions to the field of pharmacology through her innovative patent on prodrug derivatives of protein kinase C modulators demonstrate her commitment to advancing therapeutic research. Her work continues to impact academic and clinical research, paving the way for future developments in the field.